Timothy Rolph - 17 Nov 2025 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Chief Scientific Officer
Signature
/s/ Jonathan Young, Attorney-in-Fact
Issuer symbol
AKRO
Transactions as of
17 Nov 2025
Net transactions value
$0
Form type
4
Filing time
19 Nov 2025, 20:04:41 UTC
Previous filing
09 Oct 2025
Next filing
28 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rolph Timothy Chief Scientific Officer 601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO /s/ Jonathan Young, Attorney-in-Fact 19 Nov 2025 0001779479

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Gift $0 -37,100 -22% $0.000000 129,471 17 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's Common Stock that the reporting person donated as a gift to a donor advised fund.